Xilio Therapeutics is a startup based in the United States.
Based in the United States, Xilio Therapeutics is a startup.
Xilio Therapeutics develops novel antibody therapies designed to improve the safety and efficacy of cancer immunotherapy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.